Page last updated: 2024-08-05 15:48:08

EC 3.2.1.23 (beta-galactosidase) inhibitor

An EC 3.2.1.* (glycosidase) inhibitor that interferes with the action of beta-galactosidase (EC 3.2.1.23).

ChEBI ID: 132518

Members (1)

MemberDefinitionClass
3-epi-fagomineA member of the class of hydroxypiperidines that is piperidine carrying a hydroxymethyl substituent at position 2 as well as two hydroxy substituents at positions 3 and 4 (the 2R,3R,4S-diastereomer).3-epi-fagomine

Research

Studies (6)

TimeframeStudies, Drugs with This Role(%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Study Types

Publication TypeStudies, Drugs with this Role (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%

Protein Targets (5)

Inhibition Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)Drugs
Beta-galactosidaseBos taurus (cattle)IC502.250022
Ceramide glucosyltransferaseMus musculus (house mouse)IC5010.000011
Lactase-phlorizin hydrolase Rattus norvegicus (Norway rat)IC503.100022
Lysosomal acid glucosylceramidaseBos taurus (cattle)IC505.600011
Sucrase-isomaltase, intestinalRattus norvegicus (Norway rat)IC506.000011